Life AI Net
الرئيسية
الأرشيف
الحاسبات
الدليل
النشرة البريدية
تسجيل الدخول
العربية
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
الرئيسية
الأرشيف
الحاسبات
الدليل
النشرة البريدية
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
تسجيل الدخول
الرئيسية
الأرشيف
الحاسبات
الدليل
More
مباشر
Endpoints News
Health groups say HHS is trying to 'rush reinstatement' of ACIP
Endpoints News
B cell therapy maker Be Bio stops hemophilia trial
Clinical OMICs
Fibroblast Signaling Pathways Linked to Angiogenesis Differences in NSCLC
Endpoints News
FDA raises no major red flags with Moderna's flu shot
FierceBiotech
Eli Lilly’s M&A spree continues with acquisition of non-opioid pain drugmaker 4E
FierceBiotech
Amenable FDA review bodes well for Moderna's mRNA flu shot ahead of adcomm grilling
Clinical OMICs
Mini Brains Help Identify Treatment for Rare Form Parkinson’s Disease
Endpoints News
FDA greenlights Colorado's drug import proposal
Cell
The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM
FierceBiotech
PE firm Altaris scoops up AI drug development outfit Simulations Plus for $375M
BioPharma Dive
Lilly buys non-opioid pain drugmaker 4E
BioPharma Dive
Express Scripts, PCMA sue to block Tennesee law breaking up PBMs and pharmacies
Endpoints News
Health groups say HHS is trying to 'rush reinstatement' of ACIP
Endpoints News
B cell therapy maker Be Bio stops hemophilia trial
Clinical OMICs
Fibroblast Signaling Pathways Linked to Angiogenesis Differences in NSCLC
Endpoints News
FDA raises no major red flags with Moderna's flu shot
FierceBiotech
Eli Lilly’s M&A spree continues with acquisition of non-opioid pain drugmaker 4E
FierceBiotech
Amenable FDA review bodes well for Moderna's mRNA flu shot ahead of adcomm grilling
Clinical OMICs
Mini Brains Help Identify Treatment for Rare Form Parkinson’s Disease
Endpoints News
FDA greenlights Colorado's drug import proposal
Cell
The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM
FierceBiotech
PE firm Altaris scoops up AI drug development outfit Simulations Plus for $375M
BioPharma Dive
Lilly buys non-opioid pain drugmaker 4E
BioPharma Dive
Express Scripts, PCMA sue to block Tennesee law breaking up PBMs and pharmacies
الأرشيف
هذا المقال غير متوفر في الأرشيف.